Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments
Abstract Background Vendor-independent Monte Carlo (MC) dose calculation (IDC) for patient-specific quality assurance of multi-leaf collimator (MLC) based CyberKnife treatments is used to benchmark and validate the commercial MC dose calculation engine for MLC based treatments built into the CyberKn...
Main Authors: | P.-H. Mackeprang, D. Vuong, W. Volken, D. Henzen, D. Schmidhalter, M. Malthaner, S. Mueller, D. Frei, W. Kilby, D. M. Aebersold, M. K. Fix, P. Manser |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-019-1370-5 |
Similar Items
-
CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy
by: Jonathan Andrew Haas, et al.
Published: (2012-03-01) -
Successful Treatment of Metastatic Brain Tumor by CyberKnife: A Case Report
by: Cheng-Ta Hsieh, et al.
Published: (2010-03-01) -
Brain Metastases from Non-small-cell Lung Carcinoma – CyberKnife Re-irradiation after Gamma Knife Radiosurgery
by: Veselin Popov
Published: (2020-12-01) -
Treatment of circumscribed choroidal hemangioma using CyberKnife: A viable alternative
by: Aditi Agarwal, et al.
Published: (2019-01-01) -
Successful Treatment of Eccrine Porocarcinoma Metastasized to a Cervical Lymph Node with CyberKnife Radiosurgery
by: Taku Fujimura, et al.
Published: (2014-06-01)